Literature DB >> 8950975

CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases.

M A Cahill1, M E Peter, F C Kischkel, A M Chinnaiyan, V M Dixit, P H Krammer, A Nordheim.   

Abstract

Triggering of CD95 (APO-1/Fas) on different T- and B-cell lines resulted in the induction of a number of kinases (35 kDa, 38 kDa, 46 kDa and 54 kDa) that phosphorylate c-Jun and to a lesser extent Histone H1. Activation of these kinases was independent of protein biosynthesis and preceded apoptotic DNA degradation. The kinase activation pattern was specific for CD95 triggering since a variety of physical or chemical inducers of T- and B-cell apoptosis activated different kinases. The kinase activities at 46 and 54 kDa contained members of the stress-activated family of protein kinases (JNK/SAPK). Activation of the CD95-specific set of kinases was prevented by treating cells with the ICE-inhibiting peptide N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (zVAD-fmk) or by overexpression of the cow pox virus serpin CrmA. However, despite inhibition of ICE-like proteases the death signal was readily initiated at the cell membrane since a CD95 death-inducing signaling complex (DISC) was formed. Thus, our results demonstrate that ICE-like proteases in the CD95 pathway function downstream of the DISC but upstream of SAP kinases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950975

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

1.  Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation.

Authors:  R G Deschesnes; J Huot; K Valerie; J Landry
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

2.  Overexpression of LIM kinase 1 renders resistance to apoptosis in PC12 cells by inhibition of caspase activation.

Authors:  E Yang; H Kim; J Lee; J S Shin; H Yoon; S J Kim; I H Choi
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

3.  Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis.

Authors:  I Herr; D Wilhelm; T Böhler; P Angel; K M Debatin
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

4.  Cell death, tissue hypoxia and the progression of heart failure.

Authors:  H N Sabbah; V G Sharov; S Goldstein
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

5.  p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells.

Authors:  Nicholas Farley; Gustavo Pedraza-Alva; Diego Serrano-Gomez; Viswas Nagaleekar; Alexander Aronshtam; Troy Krahl; Tina Thornton; Mercedes Rincón
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

6.  TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation.

Authors:  V K Puduvalli; D Sampath; J M Bruner; J Nangia; R Xu; A P Kyritsis
Journal:  Apoptosis       Date:  2005-01       Impact factor: 4.677

7.  Dissecting Fas signaling with an altered-specificity death-domain mutant: requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation.

Authors:  H Y Chang; X Yang; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1.

Authors:  J D Graves; Y Gotoh; K E Draves; D Ambrose; D K Han; M Wright; J Chernoff; E A Clark; E G Krebs
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

9.  Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter.

Authors:  M Faris; K M Latinis; S J Kempiak; G A Koretzky; A Nel
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV.

Authors:  K Bender; M Göttlicher; S Whiteside; H J Rahmsdorf; P Herrlich
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.